BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. LEP, Response to oxidative stress, Inflammatory disorder, Neuron, Laryngoscope)
Bookmark Forward

QuickView for sulfonylurea receptors activity (biogroup)


Body Atlas

Most Correlated Tissues

  1. Heart
  2. Uterus
  3. Adipose tissue subcutaneous
  4. Colon cecum
  5. Kidney cortex
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Hypoglycemia
  2. Alpha-1-antitrypsin deficiency
  3. Disorder of endocrine system
  4. Multiple-resistant Staphylococcus aureus infection
  5. Disorder of digestive system
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. clopidogrel
  2. trimethobenzamide
  3. rabeprazole
  4. Nafenopin
  5. erlotinib
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. NSDHL
  2. BAZ1B
  3. NDUFB8
  4. CFH
  5. Cyp2g1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
  2. Spatio-temporal transcriptome of the human brain
  3. Genomics Assisted Toxicity Evaluation system study - Rat Liver Repeat Doses
  4. Liver gene expression profiles in response to dosing of rats with 8 different hepatotoxicants
  5. Livers of rat exposed to variety of hepatotoxic compounds
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Inhibition of ATP-sensitive K+ channel by a non-sulfonylurea compound KAD-1229 in a pancreatic beta-…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes
  2. Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)
  3. Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
  4. Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.
  5. GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.